Val J. Watts
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
183
Citations
5,881
Est. group size
~6
Recurring co-author estimate
Active years
37
Publishing since 1990
Val J. Watts studies adenylyl cyclases, a family of enzymes that produce the signaling molecule cAMP inside cells in response to hormones and neurotransmitters. Much of the recent work focuses on finding drug-like molecules that selectively inhibit specific adenylyl cyclase subtypes (especially AC1 and AC2), with applications to pain treatment as alternatives to opioids, as well as work relating these enzymes to immune signaling and calcium signaling pathways. This research combines pharmacology, chemistry, and cell biology to understand how these enzymes are regulated and how they could be targeted therapeutically.
Publication output has remained fairly steady over the last decade, averaging roughly 5-8 papers per year, with a notable increase in 2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Adenylyl cyclases (ACs) in GtoPdb v.2025.3
IUPHAR/BPS Guide to Pharmacology CITE · 2025
- Molecular Tools to Identify Binding Domains and a Mechanism-of-Action of Adenylyl Cyclase 1 Inhibitors as Alternatives to Opioids (Abstract ID: 171291)
Journal of Pharmacology and Experimental Therapeutics · 2025
- Studying Gαi/o-Coupled Receptor Mediated Sensitization of Adenylyl Cyclases in SH-SY5Y Neuroblastoma Cells Using Fluorescent cAMP Sensors and Live-Cell Imaging (Abstract ID: 165805)
Journal of Pharmacology and Experimental Therapeutics · 2025
- The ulcerative colitis risk gene adenylyl cyclase 7 restrains the T-helper 2 phenotype and Class II antigen presentation
Journal of Crohn s and Colitis · 2025
- A molecular mechanism to diversify Ca2+ signaling downstream of Gs protein-coupled receptors
Nature Communications · 2024
- Discovery of a Potent and Selective Human AC2 Inhibitor Based on 7-Deazapurine Analogues of Adefovir
SSRN Electronic Journal · 2023
- Adenylyl cyclases (ACs) in GtoPdb v.2023.1
IUPHAR/BPS Guide to Pharmacology CITE · 2023
- Discovery of a potent and selective human AC2 inhibitor based on 7-deazapurine analogues of adefovir
Bioorganic & Medicinal Chemistry · 2023
- The Concise Guide to PHARMACOLOGY 2023/24: Enzymes
British Journal of Pharmacology · 2023
- Editorial: Adenylyl cyclase isoforms as potential drug targets
Frontiers in Pharmacology · 2022
- Reduced activity of adenylyl cyclase 1 attenuates morphine induced hyperalgesia and inflammatory pain in mice
Frontiers in Pharmacology · 2022
- Intrathecal Knockdown of Adenylyl Cyclase 1 Attenuates Morphine Tolerance and Withdrawal in Mice
Journal of Pain · 2021
- Halogen‐Dance‐Based Synthesis of Phosphonomethoxyethyl (PME) Substituted 2‐Aminothiazoles as Potent Inhibitors of Bacterial Adenylate Cyclases
ChemMedChem · 2021
- Acyclic nucleoside phosphonates with 2-aminothiazole base as inhibitors of bacterial and mammalian adenylate cyclases
European Journal of Medicinal Chemistry · 2021
- AKAP79 Orchestrates a Cyclic AMP Signalosome Adjacent to Orai1 Ca2+ Channels
Function · 2021
- Journal of Pharmacology and Experimental Therapeutics×7
- The FASEB Journal×7
- bioRxiv (Cold Spring Harbor Laboratory)×5
- ChemMedChem×4
- Molecular Pharmacology×3
- Arryn T. Blaine
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Berkay Selçuk
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- J.J.G. Tesmer
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Richard M. van Rijn
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Susanne Prokop
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile